- $1.18m
- -$0.43m
- $19.48m
- 51
- 77
- 19
- 47
Annual cashflow statement for cbdMD, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 12.6 | -23.4 | -70.1 | -22.9 | -3.7 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | -24.3 | 11.1 | 56.1 | 16.3 | 2.66 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.7 | -1.93 | -2.77 | 0.57 | -0.463 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -10.7 | -14.1 | -15 | -4.3 | -0.353 |
Capital Expenditures | -1.32 | -0.342 | -0.689 | -0.298 | -0.29 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -0.25 | -2.21 | 0 | 1 | 0 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1.57 | -2.55 | -0.689 | 0.702 | -0.29 |
Financing Cash Flow Items | 0.062 | 0 | 0 | — | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 22.4 | 28.2 | -4.04 | -1.32 | 1.3 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 10.1 | 11.6 | -19.7 | -4.92 | 0.655 |